SYNALGOS-DC
Generic Name for SYNALGOS-DC
Dihydrocodeine bitartrate 16mg, aspirin 356.4mg, caffeine 30mg; caps.
Legal Classification:
CIII
Pharmacological Class for SYNALGOS-DC
Opioid + salicylate.
Manufacturer of SYNALGOS-DC
Women First HealthCare
|
Indications for SYNALGOS-DC
Moderate to moderately severe pain.
Adult dose for SYNALGOS-DC
2 caps every 4 hrs as needed.
Children's dosing for SYNALGOS-DC
Not recommended.
Contraindications for SYNALGOS-DC
NSAID allergy. Varicella or influenza in teenagers. Severe bleeding or coagulation disorders. Peptic ulcer. 3rd trimester pregnancy.
Precautions for SYNALGOS-DC
Asthma. Head injury. Increased intracranial pressure. Acute abdomen. Impaired renal, hepatic, thyroid, or adrenocortical function. GI or GU obstruction. Peptic ulcer. Bleeding disorders. Gastritis. Monitor blood pressure, BUN, uric acid levels. Drug abusers. Elderly. Debilitated. Pregnancy. Nursing mothers.
Interactions for SYNALGOS-DC
Potentiation with alcohol, CNS depressants, anticoagulants, hypoglycemics, plasma protein bound drugs, MAOIs, tricyclic antidepressants, anticholinergics. Alcohol, NSAIDs, corticosteroids increase risk of GI bleeding. May antagonize uricosurics.
Adverse Reactions for SYNALGOS-DC
Abuse potential, dizziness, sedation, allergic reactions, nausea, vomiting, gastric upset, constipation, urinary retention, prolonged bleeding time, respiratory depression, salicylism (overdosage).
How is SYNALGOS-DC supplied?
Caps—100, 500
Related Disease:
Pain, general~narcotics